CBD Of Denver Reports Revenue Growth, Delays Germany Spin-Off

Cannabis company CBD of Denver (OTCPK:CBDD) reported estimated third-quarter 2024 revenue of $763,450 compared to an estimated $677,893 for the same period in 2023, and provided an update on its operations in Germany.

Due to a lack of clarity in the German market, the timeline for a potential spin-off of Luxora Inc. has been extended, the company said. Last year, the company’s wholly owned subsidiary signed 4 letters of intent to build production facilities to support Cannabis Clubs with its “Production Facility Rental Model” in Germany. This year, Luxora received positive engagement in Berlin regarding a Near-Infrared (NIR) device used for cannabis testing after having success at Mary Jane Berlin trade fair, where it offered cannabis samples.

The decision to extend Luxora’s plans enables CBD of Denver to …

Full story available on Benzinga.com

Leave a Reply

Your email address will not be published. Required fields are marked *